N-acetyl lysyltyrosylcysteine amide
Modify Date: 2025-08-26 18:12:21
N-acetyl lysyltyrosylcysteine amide structure
|
Common Name | N-acetyl lysyltyrosylcysteine amide | ||
|---|---|---|---|---|
| CAS Number | 1287585-40-3 | Molecular Weight | 453.56 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C20H31N5O5S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of N-acetyl lysyltyrosylcysteine amideN-acetyl lysyltyrosylcysteine amide (KYC) is a potent, tripeptide inhibitor of myeloperoxidase (MPO), inhibits MPO-mediated hypochlorous acid (HOCl) formation (IC50=7 uM) and nitration/oxidation of LDL; completely inhibits HOCl production at 25 uM, decreases vascular oxidative stress and increases vasodilatation in sickle cell disease mice; reduces oxidative stress-mediated inflammation, neuronal damage, and neural stem cell injury in murine model of stroke. |
| Name | N-acetyl lysyltyrosylcysteine amide |
|---|
| Description | N-acetyl lysyltyrosylcysteine amide (KYC) is a potent, tripeptide inhibitor of myeloperoxidase (MPO), inhibits MPO-mediated hypochlorous acid (HOCl) formation (IC50=7 uM) and nitration/oxidation of LDL; completely inhibits HOCl production at 25 uM, decreases vascular oxidative stress and increases vasodilatation in sickle cell disease mice; reduces oxidative stress-mediated inflammation, neuronal damage, and neural stem cell injury in murine model of stroke. |
|---|---|
| References | References 1. Zhang H, et al. J Lipid Res. 2013 Nov;54(11):3016-29. 2. Zhang H, et al. J Lipid Res. 2013 Nov;54(11):3009-15. 3. Yu G, et al. J Neuroinflammation. 2016 May 24;13(1):119. 4. Rymaszewski AL, et al. Cancers (Basel). 2014 May 9;6(2):1111-27. View Related Products by Target Other Targets |
| Molecular Formula | C20H31N5O5S |
|---|---|
| Molecular Weight | 453.56 |
| InChIKey | JTHKLTJLEVKKFW-UHFFFAOYSA-N |
| SMILES | CC(=O)NC(CCCCN)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CS)C(N)=O |
| Hazard Codes | Xi |
|---|